These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21284557)

  • 1. Sustained release spherical agglomerates of polymethacrylates containing mefenamic acid: in vitro release, micromeritic properties and histological studies.
    Ozyazici M; Sevgi F; Pekcetin C; Sarpas B; Sayin S
    Pharm Dev Technol; 2012; 17(4):483-893. PubMed ID: 21284557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery.
    Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF
    Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.
    Maghsoodi M; Esfahani M
    Pharm Dev Technol; 2009; 14(4):442-50. PubMed ID: 19235551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation optimization of double emulsification method for preparation of enzyme-loaded Eudragit S100 microspheres.
    Rawat M; Saraf S
    J Microencapsul; 2009 Jun; 26(4):306-14. PubMed ID: 18686142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, characterization and in vitro evaluation of stavudine-loaded microspheres.
    Vaghani SS; Sureja S; Singh S; Gurjar M; Jivani NP; Patel MM
    Pharm Dev Technol; 2011 Apr; 16(2):146-51. PubMed ID: 20100058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of ibuprofen pellets based on Eudragit RS PO and RL PO or their combination.
    Abbaspour MR; Sadeghi F; Garekani HA
    Int J Pharm; 2005 Oct; 303(1-2):88-94. PubMed ID: 16153792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
    Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
    Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
    Muatlik S; Usha AN; Reddy MS; Ranjith AK; Pandey S
    Pak J Pharm Sci; 2007 Jul; 20(3):218-26. PubMed ID: 17545107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citric acid as a solid-state plasticizer for Eudragit RS PO.
    Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
    J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
    Devarajan PV; Sonavane GS
    Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eudragit RL100 based microspheres for ocular administration of azelastine hydrochloride.
    Shinde UA; Shete JN; Nair HA; Singh KH
    J Microencapsul; 2012; 29(6):511-9. PubMed ID: 22375685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the permeability characteristics of different polymethacrylates on the pharmaceutical characteristics of verapamil hyhdrochloride-loaded microspheres.
    Kiliçarslan M; Baykara T
    J Microencapsul; 2004 Mar; 21(2):175-89. PubMed ID: 15198429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.
    Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A
    Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation optimization of solid dispersion of mosapride hydrochloride.
    Kim HJ; Lee SH; Lim EA; Kim JS
    Arch Pharm Res; 2011 Sep; 34(9):1467-75. PubMed ID: 21975808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of mefenamic acid sustained release beads based on kappa-carrageenan.
    Ozsoy Y; Bergişadi N
    Boll Chim Farm; 2000; 139(3):120-3. PubMed ID: 10961021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro dissolution profile of zidovudine loaded microspheres made of Eudragit RS 100, RL 100 and their combinations.
    Nath B; Nath LK; Kumar P
    Acta Pol Pharm; 2011; 68(3):409-15. PubMed ID: 21648196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereospecific formulation and characterization of sustained release ibuprofen microspheres.
    Janjikhel RK; Adeyeye CM
    J Microencapsul; 1997; 14(4):409-26. PubMed ID: 9229341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.